Expediency And Quality Of Treatment Inhalation () Patients

Expediency and quality of treatment Inhalation () patients with COPD it was challenged Until recently because of lacks of an estimation and the account of complications. The truth it is shown that use can lead to some To improvement of functions of a lung within several months though is available The set of the works showing that does not improve use Long-term progressive decrease in functions of a lung, especially at Patients with 1 and 11 stages of illness. However, recent research (Towards a Revolution in COPD Health = (TORCH) has shown that the combined Application and LABA considerably reduces decrease in functions of a lung in Current 3-year-old the period. In this connection in recommendations GOLD 2006 Offer therapy of patients with started forms COPD (FEV1 < 50 from due) to spend with agents of type beclomethason'a dipropionat'a, budesonid'a, fluticason'a propionat'a, mometason'a furoat'a and triamcinolon'a acetonid'a. - Not pharmacological receptions of treatment of patients with COPD Though pharmacological agents (treatment) always Are necessary for efficient control and elimination of the negative Signs COPD, there there is a huge set not not less Pharmacological means of intervention in schemes of treatment of patients.